NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $352,721 | -90.8% | 5,865 | -88.8% | 0.01% | -87.9% |
| Q4 2022 | $3,833,711 | +12.9% | 52,266 | +16.9% | 0.07% | +13.8% |
| Q3 2022 | $3,397,000 | -49.5% | 44,705 | -44.9% | 0.06% | -55.7% |
| Q1 2022 | $6,723,000 | +122.3% | 81,151 | +101.5% | 0.13% | +65.8% |
| Q4 2021 | $3,024,000 | -22.7% | 40,282 | +19.7% | 0.08% | +9.7% |
| Q3 2021 | $3,910,000 | +45.1% | 33,658 | +177.1% | 0.07% | +46.9% |
| Q2 2021 | $2,694,000 | – | 12,145 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |